Expert Analysis

Initial Therapy, Treatment Interruption, and Induction/Maintenance

Source: CCO Independent Conference Coverage of the 2004 International AIDS Conference*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Initial Therapy, Treatment Interruption, and Induction/Maintenance

Program Director: John P. Phair, MD

Faculty:

Joseph J. Eron, Jr., MD
Joel E. Gallant, MD, MPH
W. David Hardy, MD

CREDIT INFORMATION

Release Date: August 19, 2004

Expiration Date: August 18, 2005

Physicians: maximum of 2.0 AMA PRA Category 1 Credits™

Registered Nurses: 3.2 Nursing contact hours

Pharmacists: 2.75 contact hours (0.28 CEUs)

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss the results of recent clinical studies of options for first-line antiretroviral therapy
Review new findings regarding treatment interruption strategies
Describe the outcomes of recent studies evaluating induction/maintenance approaches to antiretroviral therapy

Earn CME credit by reading the expert analysis and commentary on initial therapy. Topics covered include:

Long-term Follow-up of GS 903: Tenofovir vs Stavudine
Other Long-term Efficacy Studies
First-line Boosted-PI Regimens
Treatment Interruption
Lamivudine Monotherapy vs Treatment Interruption
Induction/Maintenance Therapy With Abacavir/Lamivudine/Zidovudine
Induction/Maintenance Therapy With Lopinavir/Ritonavir Monotherapy
Insights From Cohort Studies

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.